Ryan Mee, CEO of Fulcrum Metals, reviews FY23 and progress on the Gold Tailings Hub in Canada. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCarclo Regulatory News (CAR)

Share Price Information for Carclo (CAR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 13.00
Bid: 13.00
Ask: 13.40
Change: 0.20 (1.54%)
Spread: 0.40 (3.077%)
Open: 12.00
High: 13.00
Low: 12.00
Prev. Close: 13.00
CAR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Edison Investment Research Limited: Edison issues outlook on Carclo (CAR)

3 Oct 2017 09:42

Edison Investment Research Limited Edison Investment Research Limited: Edison issues outlook on Carclo (CAR) 03-Oct-2017 / 09:40 GMT/BST


London, UK, 3 October 2017

Edison issues outlook on Carclo (CAR)

Carclo is focusing investment on its two larger established businesses - Technical Plastics (CTP) and LED Technologies (LED). Here a differentiated offer and long-term relationships with customers provide good earnings visibility and higher probability of a sustainable return. This strategy delivered strong revenue and profits growth during FY17. Despite a temporary setback at CTP during H118, which was balanced by outperformance at LED, growth appears set to continue, underpinned by contracts with blue-chip customers.

We use a P/E-based, sum-of-the-parts methodology with three sets of sample peers drawn from the medical device manufacturing (P/E of 16.1x), automotive (mean P/E of 16.4x) and aerospace (mean P/E 20.9x) sectors to reflect the diversity of Carclo's operations. This gives an indicative valuation range of 182-193p (previously 181-191p), which is equivalent to an implied EV/EBITDA range of 8.2x-8.6x (vs peer group blended year one EV/EBITDA of 8.7x). The share price has dropped by around 13% since the AGM statement advised of short-term setbacks in the Technical Plastics division. Positive newsflow confirming the recovery in CTP should be supportive of the stock, helping to close the valuation gap.Click here to view the full report.

All reports published by Edison are available to download free of charge from its websitewww.edisoninvestmentresearch.com

About Edison: Edison is an investment research and advisory company, with offices in North America, Europe, the Middle East and AsiaPac. The heart of Edison is our world-renowned equity research platform and deep multi-sector expertise. At Edison Investment Research, our research is widely read by international investors, advisers and stakeholders. Edison Advisors leverages our core research platform to provide differentiated services including investor relations and strategic consulting.

Edison is authorised and regulated by the Financial Conduct Authority.

Edison is not an adviser or broker-dealer and does not provide investment advice. Edison's reports are not solicitations to buy or sell any securities.

For more information please contact Edison:

Anne Margaret Crow, +44 (0)20 3077 5700Dan Ridsdale, +44 (0)20 3077 5729tech@edisongroup.com

Learn more at www.edisongroup.com and connect with Edison on:

LinkedIn https://www.linkedin.com/company/edison-investment-research

Twitter www.twitter.com/Edison_Inv_Res

YouTube www.youtube.com/edisonitv


Dissemination of a FINANCIAL NEWS, transmitted by EQS Group.The issuer is solely responsible for the content of this announcement.


End of Announcement - EQS News Service

615355 03-Oct-2017 

corporate announcement transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement.

Date   Source Headline
7th Sep 20177:00 amRNSAGM Trading Update
16th Aug 20174:14 pmRNSHolding(s) in Company
17th Jul 20179:00 amRNSPerformance Share Plan
13th Jul 201711:06 amRNSDirector/PDMR Shareholding
5th Jul 20179:00 amRNSAdditional Listing
6th Jun 20177:00 amRNSFinal Results
12th May 20179:35 amRNSHolding(s) in Company
11th Apr 20177:00 amRNSYear End Trading Update
4th Apr 20174:15 pmRNSHolding(s) in Company
30th Mar 20177:00 amRNSAcquisition of FLTC (Europe) a.s.
8th Mar 20178:12 amRNSHolding(s) in Company
9th Feb 201710:53 amRNSHolding(s) in Company
31st Jan 20177:00 amRNSTrading Update
13th Jan 20179:59 amRNSHolding(s) in Company
19th Dec 20163:21 pmRNSHolding(s) in Company
16th Dec 20167:00 amRNSDirector/PDMR Shareholding
29th Nov 20163:03 pmRNSHolding(s) in Company
29th Nov 201610:49 amRNSHolding(s) in Company
18th Nov 20168:00 amRNSDirector/PDMR Shareholding
17th Nov 20169:59 amRNSHolding(s) in Company
15th Nov 20167:00 amRNSHalf-year Report
10th Nov 201610:04 amRNSHolding(s) in Company
14th Oct 20163:01 pmRNSResult of Placing
14th Oct 20167:00 amRNSTrading Update
14th Oct 20167:00 amRNSAcquisition and Placing
3rd Oct 201612:57 pmRNSHolding(s) in Company
2nd Sep 201611:49 amRNSResult of AGM
31st Aug 20167:00 amRNSUpdate on trading and dividend
18th Jul 201610:00 amRNSExercise of Options and Total Voting Rights
14th Jul 20164:21 pmRNSDirector/PDMR Shareholding
14th Jul 20164:20 pmRNSDirector/PDMR Shareholding
13th Jul 20163:42 pmRNSPerformance Share Plan
13th Jul 201612:07 pmRNSSecond Price Monitoring Extn
13th Jul 201612:02 pmRNSPrice Monitoring Extension
11th Jul 201610:15 amRNSHolding(s) in Company
8th Jul 20161:45 pmRNSAdditional Listing
27th Jun 20164:40 pmRNSSecond Price Monitoring Extn
27th Jun 20164:35 pmRNSPrice Monitoring Extension
16th Jun 201610:33 amRNSExercise of Options and Total Voting Rights
14th Jun 201611:39 amRNSHolding(s) in Company
14th Jun 20169:00 amRNSExercise of Options and Total Voting Rights
9th Jun 20164:04 pmRNSHolding(s) in Company
9th Jun 20163:34 pmRNSHolding(s) in Company
7th Jun 20163:00 pmRNSDirector/PDMR Shareholding
7th Jun 20167:00 amRNSFinal Results
16th May 20167:00 amRNSIntended Exit from Carclo Diagnostics Solutions
12th Feb 20164:40 pmRNSSecond Price Monitoring Extn
12th Feb 20164:35 pmRNSPrice Monitoring Extension
10th Feb 20164:41 pmRNSSecond Price Monitoring Extn
10th Feb 20164:36 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.